You are here

Pharma CEOs

Novartis CEO says it is watching US reciprocal tariff policy 'very carefully'

MSN/Reuters

Mon, 03/17/25 - 10:14 am

In rebound year for Pfizer, CEO Albert Bourla scored 14% total pay increase to $24.6M

Fierce Pharma

Fri, 03/14/25 - 12:01 pm

executive compensation

Moderna CEO Stéphane Bancel scored pay bump in 2024 despite revenue decline and missed sales target

Fierce Pharma

Thu, 03/13/25 - 11:36 am

Moderna Therapeutics

Stephane Bancel

executive compensation

Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024

Yahoo Finance

Wed, 03/12/25 - 11:27 am

executive compensation

As Humira succession plan played out, AbbVie's Rob Michael collected $18.5M in his first year as CEO

Fierce Pharma

Tue, 03/11/25 - 07:03 pm

executive compensation

By exercising long-held stock options, BioNTech CEO scored €260M payday in 2024

Fierce Pharma

Tue, 03/11/25 - 11:17 am

executive compensation

Bayer CEO Bill Anderson took pay cut in 2024 as company kicked off 3-year restructuring

Fierce Pharma

Mon, 03/10/25 - 09:32 am

executive compensation

'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen

Yahoo Finance

Thu, 03/6/25 - 11:39 am

Lars Jørgensen

As chikungunya launch looms, Bavarian Nordic CEO tips travel health to become the company's dominant business

Fierce Pharma

Thu, 03/6/25 - 11:34 am

Bavarian Nordic

chikungunya virus

If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M

Fierce Pharma

Fri, 02/28/25 - 11:21 am

executive compensation

Bayer CEO Bill Anderson’s war against bureaucracy

Yahoo/Fortune

Thu, 02/27/25 - 11:15 am

What did Big Pharma CEOs get paid in 2024?

Medical Marketing and Media

Thu, 02/27/25 - 11:13 am

executive compensation

Indivior changes CEO after warning sales will fall in 2025

Pharmaphorum

Thu, 02/27/25 - 10:11 am

opioid use disorder

Dr. Albert Bourla of Pfizer Becomes New Chair of PhRMA Board

PhRMA

Fri, 02/21/25 - 10:11 am

Stock stagnation prompts a 16% pay cut for AstraZeneca CEO Pascal Soriot despite strong sales sheet

Fierce Pharma

Wed, 02/19/25 - 10:42 am

executive compensation

Hiroyuki Okuzawa succeeds Sunao Manabe as Daiichi Sankyo CEO

Pharmaceutical Technology

Sun, 02/2/25 - 06:51 pm

Hiroyuki Okuzawa

Takeda CEO succession confirmed as Weber plans retirement

Pharmaphorum

Thu, 01/30/25 - 10:48 am

Christophe Weber

Teva, despite delivering in 2024, startles investors with subdued 2025 guidance

Fierce Pharma

Wed, 01/29/25 - 07:27 pm

Teva Pharmaceutical

Richard Francis

JPM25: Incyte plans to turn 'a lot of cards' in 2025 as CEO eyes 2 types of deals

Fierce Pharma

Wed, 01/22/25 - 07:24 pm

Hervé Hoppenot

JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US

Fierce Pharma

Tue, 01/14/25 - 06:21 pm

Pages